MB-huCART19.1
SP_MB21PAC
Phase 2 small_molecule active
Quick answer
MB-huCART19.1 for B-cell precursor ALL, B-cell Non Hodgkin Lymphoma is a Phase 2 program (small_molecule) at AXIM BIOTECHNOLOGIES, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AXIM BIOTECHNOLOGIES, INC.
- Indication
- B-cell precursor ALL, B-cell Non Hodgkin Lymphoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active